Sigrid Therapeutics raised €4.3M in a funding round in Jan 2026. The company is based in Stockholm, Sweden. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
